We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Relating Gene Expression to Multidrug Resistance

By Biotechdaily staff writers
Posted on 14 Sep 2004
Cancer researchers investigating the problem of multidrug resistance--development of resistance to anticancer drugs by tumor cells--have profiled the mRNA expression of the 48 known human ABC transporters in 60 diverse cancer cell lines to screen for anticancer activity and to relate gene expression to the effectiveness of anticancer drugs.

The ATP (adenotriphosphate)-binding cassette (ABC) genes represent the largest family of transmembrane proteins. More...
These proteins bind ATP and use the energy to drive the transport of various molecules across all cell membranes. Proteins are classified as ABC transporters based on the sequence and organization of their ATP-binding domains.

Investigators at the U.S. National Cancer Institute (Bethesda, MD, USA; www.nci.nih.gov) used real-time polymerase chain reaction (RT-PCR) technology to detect and quantify the expression of 48 ABC transporter genes in 60 diverse cancer cell lines. The expression of more than 68,500 genes was correlated with the growth inhibitory profiles of 1,429 candidate anticancer drugs.

Results published in the August 24, 2004, issue of Cancer Cell revealed 131 strongly inverse-correlated pairs, where cellular ABC gene expression was strongly correlated with decreased sensitivity to the drug. An unexpected finding was that expression of some ABC transporters, most notably MDR1, caused an increase in sensitivity to some drugs.

Senior author Dr. Michael Gottesman, chief of the laboratory of cell biology at NCI, said, "These results indicate that some of the ABC transporters whose function remains unknown can influence the response of cells to cancer treatment.”

The investigators recommended that research continue to identify other compounds that interact in this way with MDR1 and other ABC transporters to increase sensitivity to chemotherapeutic agents.




Related Links:
U.S.National Cancer Institute

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Drug Testing Assays
Atellica DT 250 Analyzer
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Age-Based Genetic Testing May Miss Most Inherited Cancer Risk Variants

Inherited cancer risk can influence diagnosis, treatment planning, and family screening, yet current testing practices often depend on a patient’s age at diagnosis. Many patients undergo germline genetic... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.